GSK Exceeds Expectations In Q2, But Still Awaiting Shingrix Bounce Back
Pandemic Will Continue To Affect Shingles Vaccine
While demand for Shingrix is expected to return in the US, the slow process of COVID-19 vaccination in many other countries will delay its uptake.
